跳至主要内容
临床试验/NL-OMON22021
NL-OMON22021招募中不适用

on-Invasive Cancer Test (NICT): A Pilot Study

Maastricht University Medical Center (MUMC)0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients with newly diagnosed local or metastatic breast cancer, colorectal cancer, non-small cell lung cancer and anaplastic glioblastoma, before start of radiation therapy, chemoradiation or chemotherapy.
  • 2. Patients age > 18 years, willing and able to comply with the protocol as judged by the investigator with a signed informed consent

排除标准

  • 1. Patients with a history of malignant disease other than the disease under study, with an exception for adequately treated squamous cell carcinoma of the skin, basal cell carcinoma of the skin and in situ cervix carcinoma.
  • 2. Pregnancy

研究者

发起方
Maastricht University Medical Center (MUMC)

相似试验